PNC Financial Services Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Buy |
5,543
+1,025
| +23% | +$64.8K | ﹤0.01% | 1811 |
|
|
2025
Q1 | $239K | Buy |
4,518
+4,214
| +1,386% | +$223K | ﹤0.01% | 2051 |
|
|
2024
Q4 | $17K | Buy |
304
+181
| +147% | +$10.1K | ﹤0.01% | 3608 |
|
|
2024
Q3 | $6.44K | Buy |
123
+31
| +34% | +$1.62K | ﹤0.01% | 3963 |
|
|
2024
Q2 | $3.78K | Sell |
92
-9
| -9% | -$370 | ﹤0.01% | 4078 |
|
|
2024
Q1 | $4.38K | Buy |
+101
| New | +$4.38K | ﹤0.01% | 3996 |
|
|
2023
Q2 | – | Sell |
-350
| Closed | -$6.24K | – | 4818 |
|
|
2023
Q1 | $6.24K | Hold |
350
| – | – | ﹤0.01% | 3966 |
|
|
2022
Q4 | $10.2K | Hold |
350
| – | – | ﹤0.01% | 3772 |
|
|
2022
Q3 | $9K | Hold |
350
| – | – | ﹤0.01% | 3811 |
|
|
2022
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 4373 |
|
|
2022
Q1 | $4K | Hold |
350
| – | – | ﹤0.01% | 4068 |
|
|
2021
Q4 | $3K | Hold |
350
| – | – | ﹤0.01% | 4086 |
|
|
2021
Q3 | $5K | Sell |
350
-9
| -3% | -$129 | ﹤0.01% | 3949 |
|
|
2021
Q2 | $7K | Hold |
359
| – | – | ﹤0.01% | 3802 |
|
|
2021
Q1 | $8K | Hold |
359
| – | – | ﹤0.01% | 3714 |
|
|
2020
Q4 | $11K | Hold |
359
| – | – | ﹤0.01% | 3542 |
|
|
2020
Q3 | $8K | Buy |
+359
| New | +$8K | ﹤0.01% | 3585 |
|